Please use this identifier to cite or link to this item:
Author(s): Barros, V
Pereira, M
Araújo, C
Braga, P
Azevedo, A
Title: Use of drug-eluting vs. bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study
Issue Date: 2015
Abstract: INTRODUCTION AND OBJECTIVES: The interventional cardiologist chooses a specific stent type based on the risk-benefit profile for each case. In general, drug-eluting stents should be considered in all clinical conditions, except if there are concerns or contraindications for prolonged dual antiplatelet therapy. The aim of this work was to describe the use of bare-metal vs. drug-eluting stents in patients undergoing percutaneous coronary intervention (PCI) after an acute coronary syndrome in Portuguese hospitals, according to patients' demographic and clinical characteristics and institutional characteristics. METHODS: Within the EURopean Hospital Benchmarking Processes (EURHOBOP) study, we retrospectively assessed 3009 consecutive patients in 10 Portuguese hospitals in 2009. Only patients with stents implanted during PCI (n=1194) were analyzed. RESULTS: A total of 425 patients (36%) received a bare-metal stent and 769 patients (64%) received a drug-eluting stent. A history of previous PCI, current non-ST-elevation myocardial infarction, anterior descending artery as the infarct-related artery and being initially admitted to a hospital with a catheterization laboratory were associated with drug-eluting stent implantation. Age under 45 or over 80, anemia and previous anticoagulation and/or atrial fibrillation were associated with bare-metal stent use. CONCLUSIONS: Approximately two-thirds of patients received drug-eluting stents, which were less frequently implanted in patients with ST-elevation myocardial infarction, aged over 80 years, female, with a previous history of stroke, anticoagulation and/or atrial fibrillation and anemia. Patients who had previously undergone PCI and those with the anterior descending artery as the infarct-related artery were more likely to receive a drug-eluting stent.
Subject: Acute coronary syndrome
Source: Rev Port Cardiol, vol. 34(7-8), p. 449-456
Document Type: Artigo em Revista Científica Nacional
Rights: restrictedAccess
Appears in Collections:ISPUP - Artigo em Revista Científica Nacional

Files in This Item:
File Description SizeFormat 
  Restricted Access
207.6 kBAdobe PDF    Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.